title: In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding.
authors.affiliation: Cardiology, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina 27705, USA. renato.lopes@duke.edu
authors.forename: Renato D
authors.initials: RD
authors.lastname: Lopes
authors.forename: David A
authors.initials: DA
authors.lastname: Garcia